Internal Medicine, Hematology & Oncology · Little Rock, AR
NPI
1568441368
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
10001 Lile Dr
Little Rock, AR, 72205
Phone (501) 552-6100
Groups this clinician bills Medicare through
Medicare paid, 2024
$115K
5,363 services
Medicare patients, 2024
319
Average age 74
Drug cost, 2024
$5.2M
1,992 prescriptions
Company payments, 2025
$3,737
From 41 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph M Beck II was code 36415 (venipuncture blood collection), 954 times for 281 patients. In total Joseph M Beck II billed 5,363 services in 69 codes, and Medicare paid $115K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 954 | 281 | $8.61 | $8,211 |
| 85025 Blood Count | Office | 943 | 289 | $7.55 | $7,123 |
| 80053 Clinical Chemistry | Office | 869 | 287 | $10.32 | $8,967 |
| 99214 Office E&M - Established | Office | 356 | 181 | $84.08 | $30K |
| 99213 Office E&M - Established | Office | 348 | 170 | $60.51 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 281 | 125 | $11.68 | $3,281 |
| 99212 Office E&M - Established | Office | 206 | 100 | $37.16 | $7,655 |
| 83540 Clinical Chemistry | Office | 154 | 78 | $6.27 | $965 |
| 83550 Clinical Chemistry | Office | 154 | 78 | $8.47 | $1,305 |
| 82728 Clinical Chemistry | Office | 126 | 67 | $13.27 | $1,672 |
| 84443 Clinical Chemistry | Office | 119 | 67 | $16.46 | $1,959 |
| 82533 Clinical Chemistry | Office | 105 | 36 | $15.97 | $1,677 |
| 84436 Clinical Chemistry | Office | 84 | 49 | $6.73 | $565 |
| 99232 Hospital E&M - Subsequent | Facility | 76 | 28 | $56.93 | $4,327 |
| 82746 Clinical Chemistry | Office | 75 | 60 | $14.25 | $1,068 |
By year: 2022 $132K for 6,675 services; 2023 $129K for 6,009 services; 2024 $115K for 5,363 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 954 | 281 | $8.61 | $8,211 |
| 85025 Blood Count | 943 | 289 | $7.55 | $7,123 |
| 80053 Clinical Chemistry | 869 | 287 | $10.32 | $8,967 |
| 83550 Clinical Chemistry | 154 | 78 | $8.47 | $1,305 |
| 83540 Clinical Chemistry | 154 | 78 | $6.27 | $965 |
| 82728 Clinical Chemistry | 126 | 67 | $13.27 | $1,672 |
| 84443 Clinical Chemistry | 119 | 67 | $16.46 | $1,959 |
| 82533 Clinical Chemistry | 105 | 36 | $15.97 | $1,677 |
| 84436 Clinical Chemistry | 84 | 49 | $6.73 | $565 |
| 82746 Clinical Chemistry | 75 | 60 | $14.25 | $1,068 |
Medicare prescription drug claims, 2024
In 2024, the drug Joseph M Beck II prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 338 prescriptions and refills. In total Joseph M Beck II wrote 1,992 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 338 | 338 | 37 | $1.4M |
| Juluca Dolutegravir/Rilpivirine | 136 | 136 | 14 | $479K |
| Tivicay Dolutegravir Sodium | 72 | 72 | Under 11 | $170K |
| Eliquis Apixaban | 52 | 64 | 14 | $33K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 48 | 48 | Under 11 | $183K |
| Ritonavir Generic | 47 | 53 | Under 11 | $9,483 |
| Anastrozole Generic | 47 | 106 | Under 11 | $612 |
| Isentress Raltegravir Potassium | 45 | 51 | Under 11 | $101K |
| Hydroxyurea Generic | 44 | 54 | Under 11 | $1,260 |
| Edurant Rilpivirine Hcl | 41 | 41 | Under 11 | $61K |
| Warfarin Sodium Generic | 41 | 93 | Under 11 | $274 |
| Prednisone Generic | 39 | 46 | Under 11 | $365 |
| Darunavir Generic | 35 | 41 | Under 11 | $42K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 34 | 42 | Under 11 | $197K |
| Metoprolol Tartrate Generic | 31 | 37 | Under 11 | $65.97 |
Brand drugs: 1,085 claims; generic drugs: 907 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph M Beck II $3,737 ($3,737 in general payments such as food, travel and fees) from 41 companies. The largest payer was Novartis Pharmaceuticals Corporation with $266.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 15 | $266 |
| Daiichi Sankyo Inc. 4568.T | 12 | $249 |
| Merck Sharp & Dohme LLC MRK | 10 | $230 |
| EMD Serono, Inc. MRK.DE | 9 | $203 |
| Exelixis Inc. EXEL | 9 | $186 |
| Janssen Biotech, Inc. JNJ | 8 | $171 |
| Abbvie Inc. ABBV | 8 | $170 |
| Incyte Corporation INCY | 10 | $152 |
| GlaxoSmithKline, LLC. GSK | 8 | $147 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $143 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.